Expression of ERCC1, RRM1, TUBB3 in correlation with apoptosis repressor ARC, DNA mismatch repair proteins and p53 in liver metastasis of colorectal cancer

Liver metastasis in colorectal cancer is common and the primary treatment is chemotherapy. To date, there is no routinely used test in clinical practice to predict the effectiveness of conventional chemotherapy. Therefore, biomarkers with predictive value for conventional chemotherapy would be of co...

Full description

Saved in:
Bibliographic Details
Main Authors: Tóth Csaba
Sükösd Farkas
Valicsek Erzsébet
Herpel Esther
Schirmacher Peter
Renner Marcus
Mader Christoph
Tiszlavicz László
Kriegsmann Jörg
Format: Article
Published: 2017
Series:INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 40 No. 5
doi:10.3892/ijmm.2017.3136

mtmt:3341847
Online Access:http://publicatio.bibl.u-szeged.hu/13544
LEADER 02894nab a2200301 i 4500
001 publ13544
005 20180622124744.0
008 180622s2017 hu o 0|| zxx d
022 |a 1107-3756 
024 7 |a 10.3892/ijmm.2017.3136  |2 doi 
024 7 |a 3341847  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a zxx 
100 1 |a Tóth Csaba 
245 1 0 |a Expression of ERCC1, RRM1, TUBB3 in correlation with apoptosis repressor ARC, DNA mismatch repair proteins and p53 in liver metastasis of colorectal cancer  |h [elektronikus dokumentum] /  |c  Tóth Csaba 
260 |c 2017 
300 |a 1457-1465 
490 0 |a INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE  |v 40 No. 5 
520 3 |a Liver metastasis in colorectal cancer is common and the primary treatment is chemotherapy. To date, there is no routinely used test in clinical practice to predict the effectiveness of conventional chemotherapy. Therefore, biomarkers with predictive value for conventional chemotherapy would be of considerable benefit in treatment planning. We analysed three proteins [excision repair cross-complementing 1 (ERCC1), ribonucleoside-diphosphate reductase 1 (RRM1) and class III beta-tubulin (TUBB3)] in colorectal cancer liver metastasis. We used tissue microarray slides with 101 liver metastasis samples, stained for ERCC1, RRM1 and TUBB3 and established scoring systems (fitted for tissue microarray) for each protein. In statistical analysis, we compared the expression of ERCC1, RRM1 and TUBB3 to mismatch proteins (MLH1, MSH2, MSH6 and PMS2), p53 and to apoptosis repressor protein (ARC). Statistically significant correlations were found between ERCC1, TUBB3 and MLH1, MSH2 and RRM1 and MSH2, MSH6. Noteworthy, our analysis revealed a strong significant correlation between cytoplasmic ARC expression and RRM1, TUBB3 (p=0.000 and p=0.001, respectively), implying an additional role of TUBB3 and RRM1 not only in therapy resistance, but also in the apoptotic machinery. Our data strengthens the importance of ERCC1, TUBB3 and RRM1 in the prediction of chemotherapy effectiveness and suggest new functional connections in DNA repair, microtubule network and apoptotic signaling (i.e. ARC protein). In conclusion, we showed the importance and need of predictive biomarkers in metastasized colorectal cancer and pointed out the relevance not only of single predictive markers but also of their interactions with other known and newly explored relations between different signaling pathways. 
700 0 1 |a Sükösd Farkas  |e aut 
700 0 1 |a Valicsek Erzsébet  |e aut 
700 0 1 |a Herpel Esther  |e aut 
700 0 1 |a Schirmacher Peter  |e aut 
700 0 1 |a Renner Marcus  |e aut 
700 0 1 |a Mader Christoph  |e aut 
700 0 1 |a Tiszlavicz László  |e aut 
700 0 1 |a Kriegsmann Jörg  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/13544/1/Expression_of_ERCC1_RRM1_TUBB3_u.pdf  |z Dokumentum-elérés